Improvement of mucocutaneous involvement of immunoglobulin light chain amyloidosis after chemotherapy and hematopoietic stem cell transplantation for multiple myeloma

Authors


  • Conflict of interest: None declared.

Correspondence: Manabu Ohyama, M.D., Ph.D., Department of Dermatology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Email: manabuohy@z8.keio.jp

No abstract is available for this article.

Ancillary